Medicare Enrolled
Dr. Mark Floyd, MD
Hematology & Oncology · Bryan, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Floyd from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Floyd? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Floyd
Dr. Mark Floyd is a hematology & oncology in Bryan, TX, with 14 years in practice. Based on federal Medicare data, Dr. Floyd performed 135,684 Medicare services across 2,164 unique beneficiaries.
Between the years covered by Open Payments, Dr. Floyd received a total of $8,782 from 80 pharmaceutical and/or device companies across 368 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Floyd is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice▲ Top 3% volume in TX$ $8,782 industry payments
Medicare Practice Summary
Medicare Utilization ↗135,684
Medicare services
Top 3% in TX for hematology & oncology
2,164
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9,692 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 40,500 | $1 | $2 |
| Iron infusion (Feraheme) | 37,230 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 20,000 | $43 | $100 |
| Denosumab injection (Prolia/Xgeva) | 10,260 | $18 | $45 |
| Epoetin alfa injection (Procrit) for anemia | 5,760 | $6 | $30 |
| Anti-nausea injection (fosaprepitant) | 5,100 | $0 | $3 |
| Dexamethasone injection (steroid) | 3,394 | $0 | $32 |
| Blood draw (venipuncture) | 1,788 | $8 | $16 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,450 | $1 | $55 |
| Anti-nausea injection (ondansetron/Zofran) | 1,257 | $0 | $15 |
| Complete blood count (CBC) with differential | 1,175 | $8 | $65 |
| Injection, fluorouracil, 500 mg | 1,112 | $2 | $7 |
| Injection, leucovorin calcium, per 50 mg | 851 | $3 | $20 |
| Office visit, established patient (30-39 min) | 737 | $89 | $180 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 531 | $22 | $100 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 516 | $95 | $920 |
| Administration of chemotherapy into vein, 1 hour or less | 483 | $99 | $300 |
| Office visit, established patient, complex (40-54 min) | 434 | $134 | $250 |
| Injection, potassium chloride, per 2 meq | 390 | $0 | $2 |
| Administration of additional new drug or substance into vein, 1 hour or less | 337 | $49 | $240 |
| Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | 324 | $96 | $575 |
| Drug injection, under skin or into muscle | 306 | $11 | $100 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 219 | $48 | $150 |
| Administration of chemotherapy into vein, each additional hour | 169 | $22 | $140 |
| Injection of additional new drug or substance into vein | 166 | $12 | $60 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 159 | $134 | $1,100 |
| Injection, zoledronic acid, 1 mg | 120 | $7 | $170 |
| Infusion, normal saline solution , 1000 cc | 116 | $2 | $18 |
| Injection, diphenhydramine hcl, up to 50 mg | 115 | $1 | $20 |
| Administration of prolonged chemotherapy into vein | 105 | $99 | $300 |
| Office visit, established patient (20-29 min) | 99 | $59 | $125 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 93 | $16 | $80 |
| Irrigation of implanted venous access drug delivery device | 84 | $19 | $90 |
| New patient office visit (45-59 min) | 76 | $115 | $275 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 60 | $26 | $250 |
| Application of on-body injector for under skin injection | 51 | $14 | $105 |
| Infusion into a vein for hydration, 31-60 minutes | 44 | $25 | $90 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 30 | $1 | $15 |
| Infusion into a vein for hydration, each additional hour | 22 | $10 | $115 |
| New patient office visit, complex (60-74 min) | 21 | $170 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
58.1% high complexity
38.3% medium
3.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,782
Total received (2018-2024)
Avg $1,255/year across 7 years
Top 34% in TX for hematology & oncology
80
Companies
368
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,243 (93.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$539 (6.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,824
2023$1,782
2022$1,524
2021$1,599
2020$590
2019$927
2018$535
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$631
Amgen Inc.
$569
Novartis Pharmaceuticals Corporation
$498
PFIZER INC.
$325
Dendreon Pharmaceuticals LLC
$319
E.R. Squibb & Sons, L.L.C.
$318
GlaxoSmithKline, LLC.
$313
Lilly USA, LLC
$284
Genentech USA, Inc.
$269
Seagen Inc.
$259
Astellas Pharma US Inc
$253
Celgene Corporation
$251
AstraZeneca Pharmaceuticals LP
$246
Merck Sharp & Dohme Corporation
$224
Incyte Corporation
$221
GENZYME CORPORATION
$160
Merck Sharp & Dohme LLC
$147
Myriad Genetic Laboratories, Inc.
$140
Daiichi Sankyo Inc.
$134
Takeda Pharmaceuticals U.S.A., Inc.
$132
Eisai Inc.
$132
BeiGene USA, Inc.
$127
AbbVie, Inc.
$125
JAZZ PHARMACEUTICALS INC.
$121
Ipsen Biopharmaceuticals, Inc
$120
Gilead Sciences, Inc.
$113
Boehringer Ingelheim Pharmaceuticals, Inc.
$107
Stemline Therapeutics Inc.
$103
Taiho Oncology, Inc.
$88
Tempus AI, Inc
$85
SOBI, INC
$85
Helsinn Therapeutics (U.S.), Inc.
$84
ABBVIE INC.
$84
MorphoSys, US Inc.
$76
Coherus Biosciences Inc.
$72
AVEO Pharmaceuticals, Inc.
$72
Genmab U.S., Inc.
$68
Spectrum Pharmaceuticals Inc.
$68
Regeneron Healthcare Solutions, Inc.
$62
SpringWorks Therapeutics, Inc.
$61
ARRAY BIOPHARMA INC
$61
TAIHO ONCOLOGY, INC.
$57
Foundation Medicine, Inc.
$50
Mirati Therapeutics, Inc.
$50
Rigel Pharmaceuticals, Inc.
$50
TerSera Therapeutics LLC
$48
AMAG Pharmaceuticals, Inc.
$46
EMD Serono, Inc.
$46
Adaptive Biotechnologies Corporation
$44
Pharmacyclics LLC, An AbbVie Company
$44
Bayer HealthCare Pharmaceuticals Inc.
$43
Pharmacosmos Therapeutics Inc.
$42
EISAI INC.
$39
TESARO, Inc.
$39
Agios Pharmaceuticals, Inc.
$37
Blueprint Medicines Corporation
$36
Karyopharm Therapeutics Inc.
$36
PUMA BIOTECHNOLOGY, INC.
$36
Aveo Pharmaceuticals, Inc.
$34
Tolmar, Inc.
$33
Amneal Pharmaceuticals LLC
$29
Teva Pharmaceuticals USA, Inc.
$24
Myovant Sciences Inc.
$21
AbbVie Inc.
$21
Janssen Pharmaceuticals, Inc
$20
Dova Pharmaceuticals
$20
Puma Biotechnology, Inc.
$20
Deciphera Pharmaceuticals Inc.
$19
Acceleron Pharma, Inc.
$19
Epizyme, Inc.,
$19
Clovis Oncology, Inc.
$19
ADMA BioManufacturing LLC
$19
SERVIER PHARMACEUTICALS LLC
$18
Seattle Genetics, Inc.
$16
Organon LLC
$15
Exelixis Inc.
$14
TOLMAR Pharmaceuticals, Inc.
$14
EAGLE PHARMACEUTICALS, INC.
$13
Acrotech Biopharma LLC
$12
Shield Therapeutics Inc
$12
Top 3 companies account for 19.3% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Aliqopa · BELEODAQ · BELRAPZO · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · EXKIVITY · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAVRETO · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NERLYNX · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · ORGOVYX · Onivyde · Orserdu · PADCEV · PIQRAY · PREVNAR 13 · PROMACTA · PROVENGE · PYRUKYND · Perjeta · Phesgo · Pomalyst · PreciseTumor · QINLOCK · REBLOZYL · ROLVEDON · Reblozyl · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · TAZVERIK · TECVAYLI · TIBSOVO · TIVDAK · TRUSELTIQ · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tazverik · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · VYXEOS · Vectibix · Venclexta · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ · myChoice CDx
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $6 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
7
Per 100K population
2.9
County median income
$58,388
Nearest hospital
CHI ST JOSEPH HEALTH REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Floyd is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Floyd experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Floyd performed 40,500 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Floyd receive payments from pharmaceutical companies?
Yes. Dr. Floyd received a total of $8,782 from 80 companies across 368 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Floyd's costs compare to other hematology & oncologys in Bryan?
Dr. Floyd's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Floyd) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Bryan
Browse hematology & oncologys in Bryan ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology